«It has taken us years to assemble the clinical outcome database and tissue samples, generate the
immunohistochemical biomarkers, gene expression profiles and analyse the data for this study — and we were delighted to
find a definite link between alpha beta crystallin and breast cancer progression, which we hope will ultimately improve clinical outcomes.